Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Prometheus

Is this the first true wireless monitor ever? Portable display uses Wi-Fi for connectivity and has a built in battery — shame it is only a 16-inch model that lacks touchscreen capabilities

PROMETHEUS CAST is a portable wireless monitor being crowdfunded in Japan that works with laptops, tablets and smartphones.

TechRadar

Teva Leans Into Sanofi's 'Pipeline-In-A-Product' Expertise In $1.5 Billion Deal

Teva stock tumbled Wednesday after the company announced it would partner with Sanofi to develop an inflammatory bowel disease treatment.

Investors Business Daily

Merck Outplays The Covid Decline, But Prometheus Buyout Weighs On Profits

Merck topped second-quarter expectations Tuesday, though it reported a per-share loss. Merck stock toed the line in response.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree

Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers. Here's where things stand.

Investors Business Daily

Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review

The major indexes saw modest declines, holding in a range. Tesla sold off as gross margins plunged. ISRG and DHI were earnings winners.

Investors Business Daily

Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom

Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss. The news sent RXDX stock flying Monday.

Investors Business Daily

Stocks Nudge Higher, Earnings On Deck, Merck Buys Prometheus, Netflix Axes 'Love Is Blind', Charles Schwab Reports - Five Things To Know

Stock futures edge higher with earnings, treasury yields in focus; Week Ahead: busy earnings week, housing data on deck; Prometheus Biosciences soars after $10.8 billion Merck takeover; Netflix 'Love is Blind' live event scrapped after user outage and Charles Schwab earnings up next as broker weathers bank sector storm.

The Street

Read news from The Economist, FT, and more,
with one subscription

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.